|
QuintilesIMS Real-World Insights Bibliography
| Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore |
| Author(s): Goh SY1, Tan SC2, Lim LC3, Chua B4, Hunt B5 |
| Affiliations(s): 1 Department of Endocrinology, Singapore General Hospital, Singapore
2 Health Economics & Outcomes Research, IMS Health Asia Pacific, Singapore
3 Department of Medicine, Alexandra Hospital, Singapore
4 Department of Vascular Surgery, Singapore General Hospital, Singapore
5 Ossian Health Economics and Communications, Switzerland |
| Publication(s): Journal of Diabetology, February 2015; 1:2 |
| Document Type(s): Online article |
| Countries: Singapore |
C:
Y: |
Diabetes
2015 |
|
L:
A: |
English
Cost effectiveness |
|
 |
| |
| |
| Budget Impact analysis of wider adoption of Biphasic Insulin Aspart (Biasp) in the treatment of type 2 Diabetes Mellitus (T2dm): A perspective of patients treated by public providers in Singapore |
| Author(s): Tan SC1, Matzen P2, Khoo SP2 |
| Affiliations(s): 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia 3 Novo Nordisk Pharma Singapore, Singapore |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Poster |
| Countries: Singapore |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Budget impact |
|
|
| |
| |
| Drug access through sharing public and individual responsibilities in the public healthcare system of Singapore |
| Author(s): Tan SC1, Low PY2, Chia MX2 |
| Affiliations(s): 1IMS Asia Pacific, Singapore, Singapore, 2IMS Health Asia, Singapore, Singapore |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Poster |
| Countries: Singapore |
| Click here for the abstract |
C:
Y: |
Health policy
2014 |
|
L:
A: |
English
Review |
|
|
| |
| |
| The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: India, Malaysia, Singapore, South Korea, Thailand |
C:
Y: |
Ophthalmology
2012 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand |
C:
Y: |
Ophthalmology
2012 |
|
L:
A: |
English
Burden of illness |
|
|
| |
| |
| Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas. |
| Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5 |
| Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK |
| Publication(s): European Respiratory Review 2006; 15:(98): 24-29 |
| Document Type(s): Manuscript in preparation |
| Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam |
C:
Y: |
Respiratory disease
2006 |
|
L:
A: |
English
Cost of illness |
|
|
| |
| |
|
|
|
